Simiczyjew, A., Dratkiewicz, E., Van Troys, M., Ampe, C., Styczeń, I., & Nowak, D. (2018). Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines. Cancers (Basel).

Simiczyjew, Aleksandra, Ewelina Dratkiewicz, Marleen Van Troys, Christophe Ampe, Ilona Styczeń, and Dorota Nowak. "Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines." Cancers (Basel) 2018.

Simiczyjew, Aleksandra, et al. "Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines." Cancers (Basel) 2018.